Sun Pharmaceuticals Industries Ltd
About
Sun Pharmaceuticals is one of India’s largest pharmaceutical companies with over 8% share in the domestic market. It owns 35 out of the top 300 pharmaceutical brands in India, and the top 10 of its brands contribute around 18% of India’s revenue from the pharmaceutical industry. Sun Pharmaceuticals is involved in generics, branded generics, speciality, complex or difficult-to-make technology-intensive products, over-the-counter (OTC), antiretrovirals (ARVs), active pharmaceutical ingredients (APIs), and intermediates. Its offerings are seen in multiple dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. The company’s R&D is primarily focused on neuropsychiatry, gastroenterology, anti-infectives, diabetology, and pain and analgesics. With the support of 43 manufacturing facilities, Sun Pharma and its products are found in more than 100 countries around the world, covering major markets in Canada, Australia, Western Europe, and China.
Featured In Fortune India Ranking
Financial Data 2024
Fortune India Coverage
Financial Data
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (INR Cr) | 49595 9.7% | 45207 13.5% | 39838 13.8% | 34996 5.5% | 33188 8.7% | 30525 12.7% | 27098 -16.6% | 32473 9.9% | 29539 - | 27825 66.5% | 16709 40.2% | 11916 33.3% | 8940 42.2% | 6288 47.9% | 4251 -7.2% | 4580 - |
| Net Operating Income (INR Cr) | 48497 10.51% | 43886 13.53% | 38654 15.39% | 33498 2.01% | 32838 12.98% | 29066 9.73% | 26489 -16.12% | 31578 10.85% | - | 27392 70.34% | 16080 42.31% | 11300 40.90% | 8019 40.01% | 5728 42.93% | 4007 -6.20% | 4272 27.14% |
| Profit (INR Cr) | 9576 13.0% | 8474 158.9% | 3273 12.7% | 2904 -22.9% | 3765 41.3% | 2665 27.2% | 2096 -69.9% | 6964 53.2% | 4546 - | 4539 44.5% | 3141 5.3% | 2983 12.3% | 2657 46.3% | 1816 34.4% | 1351 -25.7% | 1818 - |
| Assets (INR Cr) | 71294 6.2% | 67131 25.8% | 53376 -2.0% | 54447 -7.4% | 58774 4.5% | 56242 6.0% | 53046 2.8% | 51604 8.3% | 47670 - | 40204 56.9% | 25618 44.9% | 17681 27.5% | 13866 28.7% | 10776 31.5% | 8193 10.4% | 7421 - |
| Net Worth (INR Cr) | 63667 13.7% | 55995 16.6% | 48011 3.3% | 46463 2.7% | 45264 9.3% | 41409 8.1% | 38314 4.6% | 36640 11.1% | 32982 - | 25634 38.4% | 18525 23.6% | 14990 22.5% | 12236 29.0% | 9483 21.1% | 7829 11.1% | 7045 41.1% |
| Employee Cost (INR Cr) | 9429 13.7% | 8296 13.6% | 7301 6.4% | 6862 7.9% | 6362 6.6% | 5967 11.2% | 5367 9.5% | 4902 2.7% | 4772 6.0% | 4503 117.1% | 2074 35.2% | 1535 29.2% | 1188 45.0% | 819 104.3% | 401 17.8% | 340 - |
| Interest Cost (INR Cr) | 238 | 172 | 127 | 141 | 303 | 555 | 518 | 400 | 523 | 579 | 44 | 43 | 28 | 74 | 6 | 6 |
| Cash & Bank Balance (INR Cr) | 10521 | 5770 | 5033 | 6446 | 6488 | 7276 | 9929 | 15141 | 13182 | 10998 | 7590 | 4059 | 3367 | 2205 | 509 | 1669 |
| Total Debt (INR Cr) | 3274 | 6886 | 1290 | 3869 | 8315 | 10514 | 10385 | 9832 | 8497 | 8996 | 2561 | 260 | 321 | 426 | 171 | 179 |
Key Financial Ratios
| PARAMETERS | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit As % Of Revenues | 19.3% | 18.7% | 8.2% | 8.3% | 11.3% | 8.7% | 7.7% | 21.5% | 15.4% | 16.3% | 18.8% | 25.0% | 29.7% | 28.9% | 31.8% | 39.7% |
| Profit As % Of Assets | 13.4% | 12.6% | 6.1% | 5.3% | 6.4% | 4.7% | 4.0% | 13.5% | 9.5% | 11.3% | 12.3% | 16.9% | 19.2% | 16.9% | 16.5% | 24.5% |
| Profit As % Of Networth | 15.0% | 15.1% | 6.8% | 6.3% | 8.3% | 6.4% | 5.5% | 19.0% | 13.8% | 17.7% | 17.0% | 19.9% | 21.7% | 19.2% | 17.3% | 25.8% |
| Interest Cost to EBITDA % | 1.9% | 1.5% | 2.2% | 3.4% | 4.5% | 10.9% | 11.1% | 4.0% | 7.0% | 7.6% | 1.0% | 1.0% | 0.9% | 3.8% | 0.5% | 0.3% |
| Debt to Equity Ratio | 0.05 | 0.12 | 0.03 | 0.08 | 0.18 | 0.25 | 0.27 | 0.27 | 0.26 | 0.35 | 0.14 | 0.02 | 0.03 | 0.04 | 0.02 | 0.03 |
| RONW | 16.1% | 16.5% | 14.5% | 11.1% | 9.7% | 10.6% | 8.7% | 22.5% | 19.3% | 24.9% | 34.1% | 27.2% | 25.6% | 20.8% | 17.7% | 30.2% |
| ROCE | 17.2% | 16.8% | 18.0% | 13.6% | 9.9% | 11.0% | 10.2% | 20.7% | 17.5% | 22.9% | 34.5% | 32.3% | 27.5% | 22.3% | 18.2% | 30.7% |